Patent · US Active

Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats

US10357479B2 · kind B2 · utility

1Cited by

11References

13Claims

0Family size

Assignee

BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

Marcus Stark · Ingelheim am Rhein, DE
Ulrike D. Sent · Wiesbaden, DE
Ingo Lang · Ingelheim am Rhein, DE

Key dates

Filing date	Mar 8, 2018
Grant date	Jul 23, 2019
Priority date	—
Expiry date	Mar 8, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.